CaÑeda, Rhyle M.

HRN: 25-67-39  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/30/2025
AMOXICILLIN 250MG/5ML, 60ML SUSPENSION (BOT)
11/30/2025
12/04/2025
PO
3ml
Q 12
PCAP-C
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines